Section Arrow
TMDX.NASDAQ
- TransMedics Group
Quotes are at least 15-min delayed:2026/01/23 06:41 EST
Pre Market
Last
 138.67
+0.58 (+0.42%)
Bid
138.29
Ask
143.5
High 138.71 
Low 138.25 
Volume 305 
Regular Hours (Closed)
Last
 138.09
+4.28 (+3.20%)
Day High 
141 
Prev. Close
133.81 
1-M High
151.85 
Volume 
858.14K 
Bid
138.29
Ask
143.5
Day Low
132.02 
Open
133.6 
1-M Low
120.171 
Market Cap 
4.57B 
Currency 美元 
P/E 53.3 
%Yield -- 
10-SMA 139.4 
20-SMA 132.55 
50-SMA 130.9 
52-W High 156 
52-W Low 59.239 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.54/2.36
Enterprise Value
5.09B
Balance Sheet
Book Value Per Share
10.39
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
23.60M
Operating Revenue Per Share
5.61
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories108.61-12.12-10.04%15.3PE
Pre Market 109.27 +0.66 +0.61%
BSXBoston Scientific Corp91.29-0.42-0.46%49.04PE
Pre Market 91.12 -0.17 -0.19%
DXCMDexCom73.92+1.81+2.51%39.94PE
Pre Market 73.83 -0.09 -0.12%
PACBPacific Biosciences of California2.67+0.25+10.33%-- 
Pre Market 2.62 -0.05 -1.87%
MDTMedtronic plc101.34+1.05+1.05%27.2PE
Pre Market 101.27 -0.07 -0.07%
Industry overview quotes are at least 15 minutes delayed
Business Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.